Pulling SEC filings + quote and writing the call…
| Fiscal year | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | $27.6M | $49.0M | $71.3M | $81.1M | $79.9M | $77.4M |
| Revenue growth | — | 77.1% | 45.7% | 13.6% | -1.5% | -3.1% |
| Gross profit | $18.4M | $40.3M | $59.0M | $69.2M | $68.3M | $66.7M |
| Gross margin | 66.7% | 82.4% | 82.7% | 85.3% | 85.5% | 86.2% |
| Operating income | -$32.2M | -$51.5M | -$84.0M | -$57.3M | -$50.5M | -$37.1M |
| Operating margin | -116.5% | -105.2% | -117.7% | -70.7% | -63.3% | -48.0% |
| Net income | -$34.7M | -$63.0M | -$86.2M | -$55.5M | -$51.5M | -$38.4M |
| Net margin | -125.5% | -128.6% | -120.9% | -68.5% | -64.5% | -49.7% |
| EPS (diluted) | -$3.71 | -$2.36 | -$1.80 | -$1.14 | -$1.03 | -$0.74 |
| Fiscal year | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Operating cash flow | -$32.2M | -$52.5M | -$76.0M | -$47.2M | -$22.4M | -$29.7M |
| Capital expenditures | $953K | $813K | $970K | $791K | $385K | $224K |
| Free cash flow | -$33.1M | -$53.4M | -$76.9M | -$48.0M | -$22.7M | -$29.9M |
| Fiscal year | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $61.5M | $261M | $185M | $138M | $120M | $92.0M |
| Total assets | $72.8M | $280M | $213M | $167M | $143M | $115M |
| Total liabilities | $44.3M | $48.1M | $53.0M | $46.4M | $55.3M | $51.4M |
| Long-term debt | $32.0M | $32.7M | $33.3M | $31.7M | $39.4M | $40.3M |
| Shareholders' equity | -$88.8M | $232M | $160M | $120M | $87.5M | $63.9M |
| Retained earnings | -$90.0M | -$153M | -$239M | -$295M | -$346M | -$385M |
| Shares (wtd avg diluted) | 9.51M | 26.7M | 47.8M | 48.6M | 50.1M | 52.1M |
Every figure is extracted from Sight Sciences, Inc.’s annual reports as filed with the SEC (XBRL company facts) — no third-party estimates. Fiscal years are labeled by period end; filers occasionally re-tag concepts, so a sparse cell means the company didn’t report that concept for that year. Free cash flow = operating cash flow − capital expenditures.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.